Time below range

Biomarker

8 papers2 findings

  • Human trial2
  • Humans5
  • In silico1

Interventions

2

GLP-1 receptor agonists

no changein humans1

1 study
  1. GLP-1 receptor agonists have no effect on time below range in humans.

    “No changes on time below range were observed”

    Humansin DM1 patients with obesity using MiniMed 780G AID1 year

    Addition of GLP-1 Analogs to DM1 Patients Using Automatic Insulin Delivery (AID) (MiniMed 780G): A Retrospective Real-Life Study

    ADA Scientific Sessions 2026 abstract5 Jun 2026

More on GLP-1 receptor agonists

Adjunctive pharmacotherapy

no changein humans1

1 study
  1. Adjunctive pharmacotherapy has no effect on time below range in humans (averaged 2%).

    “Time below range averaged 2% and did not change.”

    Humansin type 1 diabetes using open-source automated insulin delivery systems12 monthsn = 357

    Beyond Insulin Alone: One-Year CGM Outcomes of Adjunctive Incretin-Based and SGLT2 Inhibitors Therapy in Type 1 Diabetes Using Open-Source Automated Insulin Delivery Systems

    ADA Scientific Sessions 2026 abstract5 Jun 2026

More on Adjunctive pharmacotherapy

Latest

Nov 2025: 3Dec 2025: 2Jan 2026: 1Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 13Jul 2026: 0Aug 2026: 8Sep 2026: 1Oct 2026: 230 in 12 months